Recommended Topic Related To:

Miradon

"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...

Miradon

Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

PATIENT INFORMATION

The physician should instruct patients:

  • To follow carefully the physician's directions for taking this drug and not to alter these directions without authorization.
  • To follow carefully the physician's directions for the periodic blood test (prothrombin time)re-quired to assure that the correct dose of the drug is being used.
  • To discuss with the physician any other medication (prescription or nonprescription) to be used.
  • To report to the physician any abnormal bleeding, such as blood in the urine, blood in the stool (a black, tarry appearance); bleeding from the gums or nose; patches of discoloration or bruises on the arms, legs, or toes; or excessive bleeding following minor cuts (eg, while shaving).
  • To discuss with the physician any plan to become pregnant or to report any pregnancy promptly.

Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.